Enmoore Lin
Overview
Explore the profile of Enmoore Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
33
Citations
1809
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Naung M, Martin E, Wong W, Razook Z, Utama D, Guy A, et al.
Front Parasitol
. 2025 Jan;
2():1288867.
PMID: 39816834
Reticulocyte Binding Protein Homologue (RH5), a leading malaria vaccine candidate, is essential for erythrocyte invasion by the parasite, interacting with the human host receptor, basigin. RH5 has a small number...
2.
Kotwal S, Perkovic V, Jardine M, Kim D, Shah N, Lin E, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2449998.
PMID: 39661388
Importance: Chronic kidney disease (CKD) is a global health priority affecting almost 1 billion people. New therapeutic options and clinical trial innovations such as adaptive platform trials provide an opportunity...
3.
Zhao G, Roder D, White S, Lin E, Challam S, Little A, et al.
Cancer Epidemiol
. 2022 Aug;
80:102243.
PMID: 36037560
Introduction: Cancer care and outcomes differ across cultural groups in Australia. Quantifying these differences facilitates prioritisation and targeting of services and research. All-of-population data are needed by health agencies to...
4.
Hockham C, Kotwal S, Wilcox A, Bassi A, McGree J, Pollock C, et al.
Trials
. 2021 Aug;
22(1):573.
PMID: 34454580
Background: SARS-CoV-2 binds to membrane-bound angiotensin-converting enzyme 2 (ACE2) which may result in downregulation of membrane-bound ACE2. ACE2 is a key regulator of the renin-angiotensin system (RAS) and is responsible...
5.
Fitzadam S, Lin E, Creighton N, Currow D
Intern Med J
. 2020 Jul;
51(6):879-890.
PMID: 32638476
Background: Aboriginal Australians have higher cancer mortality than non-Aboriginal Australians. Lower rates of cancer treatment among Aboriginal people can contribute to this. Aims: To investigate demographic, clinical and access factors...
6.
DeMaere M, Liu M, Lin E, Djordjevic S, Charles I, Worden P, et al.
Microbiol Resour Announc
. 2020 Feb;
9(6).
PMID: 32029559
We report the availability of a high-quality metagenomic Hi-C data set generated from a fecal sample taken from a healthy fecal microbiome transplant donor subject. We report on basic features...
7.
Tessema S, Nakajima R, Jasinskas A, Monk S, Lekieffre L, Lin E, et al.
Cell Host Microbe
. 2019 Nov;
26(5):579-590.e5.
PMID: 31726028
Extreme diversity of the major Plasmodium falciparum antigen, PfEMP1, poses a barrier to identifying targets of immunity to malaria. Here, we used protein microarrays containing hundreds of variants of the...
8.
Tervonen H, Chen T, Lin E, Boyle F, Moylan E, Della-Fiorentina S, et al.
Eur J Cancer Care (Engl)
. 2019 Jun;
28(5):e13125.
PMID: 31222826
Objective: To examine risk of emergency hospital admission and survival following adjuvant chemotherapy for early breast cancer. Methods: Linked data from New South Wales population-based and clinical cancer registries (2008-2012),...
9.
Lin E, Chen T, Little A, Holliday L, Roach P, Butler P, et al.
Intern Med J
. 2019 May;
49(10):1268-1277.
PMID: 31062490
Background: Peptide receptor radionuclide therapy with Lu-DOTATATE is a promising treatment for inoperable or metastatic neuroendocrine tumours (NET). In 2015, the NSW Ministry of Health provided funding for Lu-DOTATATE treatment...
10.
Paramsothy S, Nielsen S, Kamm M, Deshpande N, Faith J, Clemente J, et al.
Gastroenterology
. 2018 Dec;
156(5):1440-1454.e2.
PMID: 30529583
Background & Aims: Fecal microbiota transplantation (FMT) can induce remission in patients with ulcerative colitis (UC). In a randomized controlled trial of FMT in patients with active UC, we aimed...